ArticlePloS one2017

Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia.

Shovik Bandyopadhyay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.